cephradine

Key facts

INN

cephradine

Brand

VELOSEF

Route

INJECTION

Formulation

FOR SUSPENSION

Originator

TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 12383566

Inhibition of SLC transporter activity or expression to attenuate anthracycline-

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12365659

Non-polyamine based polyamine transport inhibitors and their use in the treatmen

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12350510

Magnetic microwires for energy-transporting biomedical applications

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12336835

Neuromodulation to target glucose transporter and/or incretin pathways

Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12329780

Acute and chronic mitochondrial electron transport chain dysfunction treatments

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12291508

Hydrazide containing nuclear transport modulators and uses thereof

Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12247973

Plasma membrane citrate transporter for use in the diagnosis and treatment of ca

Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12173306

Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transpo

Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is cephradine?

cephradine (VELOSEF), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for cephradine?

VELOSEF is a marketed brand name for cephradine. Check FDA Drugs@FDA for the current US label holder.